An Irish newspaper, the Evening Herald, reports that diabetics in Europe have been warned about a drug used to lower blood sugar, which has been linked to severe side-effects.
According to the report, patients have suffered “serious hypersensitivity reactions” including anaphylactic shock and acute pancreatitis.
Both the Irish Medicines Board and the European Medicines Agency issued warnings about the drug saxagliptin, which has the brand name Onglyza, prescribed for patients with Type 2 diabetes as part of a diet and exercise program ...
continue reading...